Corporate/M&A
Asia-Pacific Guide 2025 : Asia-Pacific Region
Band 4
Email address
[email protected]Contact number
+852 2971 4888Chambers Review
Milbank has an established corporate team based in Singapore, with deep and longstanding expertise relating to Indonesia. The team also handles M&A transactions and private equity work across the wider South-East Asia region, including in Vietnam and the Philippines. In Greater China, the firm has a growing presence in the private equity space, acting for international and regional investors and corporates on investments, LBOs and exits. It is especially active in the healthcare, finance and technology sectors.
Jacqueline Chan and David Zemans are key contacts in Singapore, and Andrew Whan and Neeraj Budhwani are key contacts in Hong Kong.
Work Highlights
- Milbank advised Kimia Farma andKimia Farma Apotek on the sale of a minority stake in the companies to Silk Road Fund and Indonesia Investment Authority.
Strengths
Provided by Chambers
"The team is excellent at working across multiple countries across Asia to execute highly complicated transactions that span commercial, regulatory and tax issues across jurisdictions."
"Milbank is my preferred M&A adviser for South-East Asian transactions. Its ability to stay on top of evolving regulatory frameworks but put on a commercial lens to facilitate deals is top-notch."
"The team is excellent at working across multiple countries across Asia to execute highly complicated transactions that span commercial, regulatory and tax issues across jurisdictions."
"Milbank is my preferred M&A adviser for South-East Asian transactions. Its ability to stay on top of evolving regulatory frameworks but put on a commercial lens to facilitate deals is top-notch."